|
NR4A1: nuclear receptor subfamily 4, group A, member 1: Hs.1119
|
|
CYR61: cysteine-rich, angiogenic inducer, 61: Hs.8867
|
|
CXCL2: chemokine (C-X-C motif) ligand 2: Hs.75765
|
|
RAB21: member RAS oncogene family: Hs.184627
|
|
CTGF: connective tissue growth factor: Hs.75511
|
|
CXCL3: chemokine (C-X-C motif) ligand 3: Hs.89690
|
|
TCEB3: transcription elongation factor B (SIII): Hs.155202
|
|
IGLL1: immunoglobulin lambda-like polypeptide 1: Hs.348935
|
|
CTGF: connective tissue growth factor: Hs.75511
|
|
IGHG3: immunoglobulin heavy constant gamma 3: Hs.413826
|
|
C1QB: complement component 1, q subcomponent beta: Hs.8986
|
|
CYR61: cysteine-rich, angiogenic inducer, 61: Hs.8867
|
|
C1QG: complement component 1, q subcomponent gamma:Hs.94953
|
|
TAGLN: transgelin: Hs.433399
|
|
CD163: Hs.74076
|
|
GSTA4: glutathione S-transferase A4: Hs.169907
|
|
Negative Significant Genes: Lower in pleural vs. ascites
|
|
N33: Putative prostate cancer tumor suppressor: Hs.71119 100791
|
|
PLEC1: plectin 1, intermediate filament binding protein 500 kDa: Hs.79706
|
|
SLC40A1: solute carrier family 40, member 1: Hs.5944
|
